Future Healthcare Dinner by Caresyntax held in Almaty

On June 28, 2024, the 56th Future Healthcare Dinner by Caresyntax was held in Almaty, organized jointly with the investment management company Fonte Capital and the specialized healthcare expansion and growth capital investment firm TVM Capital Healthcare.

The international series of "Future of Healthcare" dinners and luncheons by Caresyntax brings together entrepreneurs, investors,  the biggest players in surgery, health system leaders, tech visionaries, policy makers, and other stakeholders to discuss the future of the healthcare industry. In May and June 2024 alone, events were held in New York, London, Milan, Geneva, Paris, Zurich, Munich, and Almaty.

The dinner included presentations on the development of the global healthcare industry and advanced trends in this field. The evening was opened with a welcoming speech by the CEO of Fonte Capital, Yerzhan Mussin. The speakers included the founder and CFO of Caresyntax, Bjoern von Siemens, Vice President of Strategy and Corporate Development Bracy Fertig, CEO of Cure Capital Advisors David Cubbin, and Chairman and CEO of TVM Capital Healthcare Dr. Helmut M. Schuehsler.

"We build regional healthcare leaders by leveraging regional and global market dynamics, injecting equity capital, supporting operations with our international experts and bringing long-standing domain expertise" noted Dr. Helmut M. Schuehsler, Chairman and CEO of TVM Capital Healthcare.

During the speech, Caresyntax's Vice President of Strategy and Corporate Development Bracy Fertig shared the company's performance results and highlighted some key achievements to date: "Healthcare is a global industry with a turnover of over $10 trillion, dominated by hospitals and the US market, with low digital penetration. Surgery accounts for 30% of the global healthcare market – over $3.0 trillion. Caresyntax aims to make surgery smarter and safer. The company's mission is to integrate AI-powered software, devices, and clinical services to improve surgical outcomes. The platform generates insights at all stages of care: preoperatively by optimizing the surgical workflow, intraoperatively with real-time support tools, and postoperatively with clinical safety modules. Today, Caresyntax software is used in over 3,000 ORs globally, serving 30,000 surgical users and aids surgical teams in over three million procedures annually”. 

Yerzhan Mussin shared plans for developing cooperation between Fonte Capital and Caresyntax: "As one of the leading investment management companies in Kazakhstan, Fonte Capital is pleased to be at the forefront of global healthcare development and technological advancement. We are considering the creation of a sub-fund for Caresyntax within  Fonte Emerging Markets Umbrella Fund OEIC Limited  to further support leading innovations and transformational initiatives in healthcare worldwide."